J&J dumps Aegis Group's Carat

Johnson & Johnson dumped Aegis Group's Carat as it began a root-and-branch review of its media planning and buying assignments, according to Advertising Age. Carat had handled media on a number of the Pfizer OTC brands being acquired by J&J. Those brands will be divided up among roster agencies that survive the review, Ad Age reported.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions